Alpine immune investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of alpine immune sciences, inc. - alpn

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of alpine immune sciences, inc. (nasdaqgm: alpn) to vertex pharmaceuticals incorporated (nasdaqgs: vrtx). under the terms of the proposed transaction, shareholders of alpine will receive $65.00 in cash for each share of alpine that they own. ksf is seeking to determine whether this consideration and the process t.
VRTX Ratings Summary
VRTX Quant Ranking